ClinicalTrials.gg
Not yet recruitingNCT07868471Updated Oct 9, 2026

Community Active and Healthy Families Pragmatic Trial

A Phase 4 interventional study of Community Active and Healthy Families Intensive Health Behavior and Lifestyle Treatment in Child Obesity, sponsored by University of Colorado, Denver. Not yet recruiting. Open to participants aged 5 Years to 99 Years. Per ClinicalTrials.gov, last updated 2026-10-09.

Sponsored by University of Colorado, Denver · Phase 4, Interventional, and Treatment

Updated Oct 9, 2026Newly registeredGo to Updates ↓
Phase
Phase 4
Study type
Interventional
Enrollment
416
Allocation
Randomized
Ages
5 Years to 99 Years
Sex
All
01

Study summary

This is a randomized pragmatic trial of the Community-AHF intervention to evaluate its effectiveness at decreasing body mass index in 5-12 year old children.

02

Conditions studied

  • Child Obesity

Browse trials for

03

In context

Pediatric Obesity

1,126 studies on the registry are indexed under Pediatric Obesity; 189 are open to participants now.

This study's planned enrollment of 416 is above the median of 103 across 869 interventional studies indexed under Pediatric Obesity.

Browse Pediatric Obesity studies →

Lead sponsor

University of Colorado, Denver is the lead sponsor of 1,538 studies on the registry; 319 are open to participants now.

Of its 146 completed or terminated interventional studies of FDA-regulated products, 92 (63%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
5 Years to 99 Years
Sexes eligible
All
Accepts healthy volunteers
No

Eligibility criteria

Inclusion Criteria:• For child participants

  • Age 5-12 AND
  • BMI > 85th%tile for age and sex AND
  • No medical contraindication to diet modification or engaging in physical activity.

      • For parent participants
  • Self-identifies as Latino/Hispanic AND
  • Self-identifies as foreign-born AND
  • Self-identifies as Spanish-speaking AND
  • Age ≥ 18 years AND
  • No medical contraindication to diet modification or engaging in physical activity.

Exclusion Criteria:

-

05

Study design

Phase
Phase 4
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Investigator, Outcomes assessor)
Enrollment
416 participants (estimated)

Study arms

  • No intervention
    Wait-list control
  • Experimental
    Community Active and Healthy Families

    Behavioral: Community Active and Healthy Families Intensive Health Behavior and Lifestyle Treatment

Interventions

  • BehavioralCommunity Active and Healthy Families Intensive Health Behavior and Lifestyle Treatment

    Intensive Health Behavior and Lifestyle Treatment that is community-based and designed for Latino families with children with overweight and obesity

06

What researchers measure

Primary outcomes

  1. Change in %BMIp95-Primary

    Change in %BMIp95 from baseline to 4 months

    Time frame: Baseline-4 months

07

Study locations

No study locations are listed for this record.

08

References and documents

Publications

  • DeCamp LR, Valdez-Vormezeele J, Molino E, Musci R, Vuillier J, Delgado Hernandez M, Marroquin Miranda MY, Caicedo IP, Garcia-Hernandez S, Huebschmann AG, Fort MP, Thompson DA, Perrin E, Polk S. Mixed Methods Evaluation of a Community-Based Weight Management Program for Latino Children. Am J Health Promot. 2026 Jun 1:8901171261454826. doi: 10.1177/08901171261454826. Online ahead of print. PubMed 42224506 ↗

Individual participant data

Plan to share: Undecided

09

Updates

1 registry update since Sep 25, 2026
Registered
First appeared on the registry. No changes since
Oct 9, 2026
Show all 1 update
  1. Oct 9, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07868471
Responsible party
Sponsor
First posted
Oct 9, 2026
Start date
Jan 1, 2028 (estimated)
Primary completion
Jun 30, 2031 (estimated)
Completion
Jun 30, 2032 (estimated)
Last update
Oct 9, 2026

Study contacts

Lisa DeCamp, MD, MSPH
Contact
lisa.decamp@cuanschutz.edu
3037246499

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion